公开(公告)号：AU2007201527B2

公开(公告)日：2012-08-09

申请号：AU2007201527

申请日：2007-04-05

Applicant: SERVIER LAB

Inventor： DELALLEAU BRUNO ,  FABIANO AGNES ,  MILLAN MARK ,  MOCAER ELISABETH

IPC: A61K31/165 ,  A61P25/22

Abstract: USE OF AGOMELATINE IN OBTAINING MEDICAMENTS INTENDED FOR THE TREATMENT OF GENERALIZED ANXIETY DISORDER 5 The present invention relates to the use of agomelatine, or N-[2-(7-methoxy-1 naphthyl)ethylacetamide, in obtaining medicaments intended for the treatment of Generalized Anxiety Disorder.

公开(公告)号：PL1842535T3

公开(公告)日：2011-01-31

申请号：PL07290420

申请日：2007-04-06

Applicant: SERVIER LAB

Inventor： DELALLEAU BRUNO ,  FABIANO AGNES ,  MILLAN MARK ,  MOCAER ELISABETH

IPC: A61K31/165 ,  A61P25/22

公开(公告)号：HRP20100577T1

公开(公告)日：2010-11-30

申请号：HRP20100577

申请日：2010-10-21

Applicant: SERVIER LAB

Inventor： DELALLEAU BRUNO ,  FABIANO AGNES ,  MILLAN MARK ,  MOCAER ELISABETH

IPC: A61K31/165 ,  A61P25/22

Abstract: Use of agomelatine or N-[2-(7-methoxynaphthalen-1-yl)ethyl]acetamide or its hydrates, crystalline forms and acid/base additive salts, to obtain a drug for the treatment of generalized anxiety disorders. An independent claim is included for a composition comprising agomelatine, optionally in combination with excipients, for the manufacture of a drug to treat generalized anxiety disorders. ACTIVITY : Tranquilizer; Antidepressant; Hypnotic; Cardiovascular-Gen; Gastrointestinal-Gen; Anorectic. MECHANISM OF ACTION : Melatoninergic system receptors agonist; 5-HT2c receptor antagonist.

公开(公告)号：SI1842535T1

公开(公告)日：2010-10-29

申请号：SI200730345

申请日：2007-04-06

Applicant: SERVIER LAB

Inventor： DELALLEAU BRUNO ,  FABIANO AGNES ,  MILLAN MARK ,  MOCAER ELISABETH

IPC: A61K31/165 ,  A61P25/00

公开(公告)号：EA014288B1

公开(公告)日：2010-10-29

申请号：EA200601449

申请日：2006-09-08

Applicant: SERVIER LAB

Inventor： DELALLEAU BRUNO

IPC: A61K31/165 ,  A61P25/20 ,  A61P25/24

Abstract: Настоящееизобретениеотноситсяк применениюагомелатина, N-[2-(7-метокси-1-нафтил)этил]ацетамида, дляприготовлениялекарственныхсредств, предназначенныхдлялечениянарушенийснау пациентас депрессией.

公开(公告)号：GEP20094743B

公开(公告)日：2009-07-27

申请号：GEAP2007009966

申请日：2007-04-05

Applicant: SERVIER LAB

Inventor： MOCAER ELISABETH ,  MILLAN MARK ,  FABIANO AGNES ,  DELALLEAU BRUNO

IPC: A61P25/22 ,  A61K31/165

Abstract: Use of agomelatine or N-[2-(7-methoxynaphthalen-1-yl)ethyl]acetamide or its hydrates, crystalline forms and acid/base additive salts, to obtain a drug for the treatment of generalized anxiety disorders. An independent claim is included for a composition comprising agomelatine, optionally in combination with excipients, for the manufacture of a drug to treat generalized anxiety disorders. - ACTIVITY: Tranquilizer; Antidepressant; Hypnotic; Cardio¬vas¬cu¬lar-Gen; Gastrointestinal-Gen; Anorectic. – ME¬CHANISM OF ACTION : Melatoninergic system receptors agonist; 5-HT2c receptor antagonist.

公开(公告)号：MX2007004100A

公开(公告)日：2009-02-16

申请号：MX2007004100

申请日：2007-04-04

Applicant: SERVIER LAB

Inventor： MILLAN MARK ,  MOCAER ELISABETH ,  DELALLEAU BRUNO ,  FABIANO AGNES

IPC: A61K31/00

Abstract: La presente invención se refiere a la utilización de la agomelatina o N-[2-(7-metoxi-1-nafti1)etillacetamidapara la obtención de medicamentos destinados al tratamiento del trastorno de ansiedad generalizada.

公开(公告)号：NZ549726A

公开(公告)日：2008-03-28

申请号：NZ54972606

申请日：2006-09-07

Applicant: SERVIER LAB

Inventor： DELALLEAU BRUNO

IPC: C07C233/18 ,  C07C233/60 ,  A61K31/16 ,  A61P25/24 ,  A61K31/165

Abstract: Disclosed is a use of agomelatine or N-[2-(7-methoxy-1-naphthyl)ethyl]acetamide or its hydrates, crystalline forms and addition salts with a pharmaceutically acceptable acid or base in the manufacture of a medicaments which are intended for the treatment of sleep disorders among depressed patients.

公开(公告)号：CA2584060A1

公开(公告)日：2007-10-07

申请号：CA2584060

申请日：2007-04-10

Applicant: SERVIER LAB

Inventor： DELALLEAU BRUNO ,  FABIANO AGNES ,  MOCAER ELISABETH ,  MILLAN MARK

IPC: A61K31/165 ,  A61P25/22

Abstract: La présente invention concerne l'utilisation de l'agomélatine ou N-[2-(7- méthoxy-1- naphtyl)éthyl]acétamide pour l'obtention de médicaments destinés au traiteme nt du Trouble Anxiété Généralisée.

公开(公告)号：CY1111287T1

公开(公告)日：2015-08-05

申请号：CY101100897

申请日：2010-10-07

Applicant: SERVIER LAB

Inventor： DELALLEAU BRUNO ,  FABIANO AGNÈS ,  MILLAN MARK ,  MOCAER ELISABETH

IPC: A61K31/165 ,  A61P25/22

Abstract: Ηπαρούσαεφεύρεσηαφοράτηνχρήσητηςαγομελατίνηςή Ν-[2-(7-μεθοξυ-1 -ναφθυλ)αιθυλ)ακεταμιδίουγιατηνλήψηφαρμάκωνπουπροορίζονταιγιατηνθεραπείαδιαταραχήςγενικευμένουάγχους.